Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Siegrist

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
International Reviews of Immunology|April 14, 2000
Vaccination in the neonatal period and early infancyC A Siegrist
Vaccine|June 1, 1997
Potential advantages and risks of nucleic acid vaccines for infant immunizationC A Siegrist
Revue Medicale Suisse|November 29, 2012
[New Swiss recommendations for adult boosters against pertussis, tetanus and diphtheria]C-A Siegrist
Revue Medicale Suisse|March 16, 2007
[First glance at the 2007 national immunization plan]C A Siegrist
Archivum Immunologiae Et Therapiae Experimentalis|August 2, 2001
The search for novel adjuvants for early life vaccinations: can "danger" motifs show us the way?J Kovarik, C A Siegrist
European Journal of Immunology|November 1, 1993
Antisense oligonucleotides specific for regulatory factor RFX-1 inhibit inducible but not constitutive expression of all major histocompatibility complex class II genesC A Siegrist, B Mach
Immunology and Cell Biology|July 31, 1998
Optimization of vaccine responses in early life: the role of delivery systems and immunomodulatorsJ Kovarik, C A Siegrist
Sozial- Und Praventivmedizin|December 2, 1998
[Vaccination against hepatitis B]D Desgrandchamps, C A Siegrist
Jac-Antimicrobial Resistance|June 18, 2024
Ceftaroline in CNS and ocular infections: a case seriesEmily A Siegrist, Joseph Sassine
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2022
Antivirals With Activity Against Mpox: A Clinically Oriented ReviewEmily A Siegrist, Joseph Sassine
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
International Reviews of Immunology|April 14, 2000
Vaccination in the neonatal period and early infancyC A Siegrist
Vaccine|June 1, 1997
Potential advantages and risks of nucleic acid vaccines for infant immunizationC A Siegrist
Revue Medicale Suisse|November 29, 2012
[New Swiss recommendations for adult boosters against pertussis, tetanus and diphtheria]C-A Siegrist
Revue Medicale Suisse|March 16, 2007
[First glance at the 2007 national immunization plan]C A Siegrist
Archivum Immunologiae Et Therapiae Experimentalis|August 2, 2001
The search for novel adjuvants for early life vaccinations: can "danger" motifs show us the way?J Kovarik, C A Siegrist
European Journal of Immunology|November 1, 1993
Antisense oligonucleotides specific for regulatory factor RFX-1 inhibit inducible but not constitutive expression of all major histocompatibility complex class II genesC A Siegrist, B Mach
Immunology and Cell Biology|July 31, 1998
Optimization of vaccine responses in early life: the role of delivery systems and immunomodulatorsJ Kovarik, C A Siegrist
Sozial- Und Praventivmedizin|December 2, 1998
[Vaccination against hepatitis B]D Desgrandchamps, C A Siegrist
Jac-Antimicrobial Resistance|June 18, 2024
Ceftaroline in CNS and ocular infections: a case seriesEmily A Siegrist, Joseph Sassine
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2022
Antivirals With Activity Against Mpox: A Clinically Oriented ReviewEmily A Siegrist, Joseph Sassine
Pageof 12